Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Shenqi Fuzheng injection SQ001

An injectable formulation composed of the two Chinese medicinal herbs Radix astragali, the root of astragalus membranaceus (huangqi) and Radix codonopsis, the root of Codonopsis pilosula (dangshen), with potential antineoplastic adjuvant and chemoprotective activities that may prevent cancer-related fatigue. Although the exact mechanisms by which shenqi fuzheng injection (SFI) have yet to be fully elucidated, the herbs may improve tumor response and/or reduce the toxicity of certain chemotherapeutics when administered together. It may also alleviate chemotherapy-associated immunosuppression.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Abbreviation:	SFI
Code name:	SQ 001 SQ-001 SQ001

Shenqi Fuzheng injection SQ001

Search NCI's Drug Dictionary